During the past decade, Central Clinical Hospital of the MSWiA in Warsaw conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Clinical Hospital of the MSWiA in Warsaw" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland" with 2 trials sponsored, "John Paul II Hospital, Krakow" with 2 trials sponsored, "AtriCure, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Clinical Hospital of the MSWiA in Warsaw" #1 collaborator was "KCRI" with 2 trials as a collaborator, "National Center for Research and Development, Poland" with 2 trials as a collaborator, "Cardialysis BV" with 1 trials as a collaborator, "Centro per la Lotta Contro l'Infarto - Fondazione Onlus" with 1 trials as a collaborator and "University National Heart Hospital" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Central Clinical Hospital of the MSWiA in Warsaw" are "Coronary Artery Disease" (3 trials), "Colitis, Ulcerative" (2 trials), "Atrial Fibrillation" (1 trials), "Crohn Disease" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Central Clinical Hospital of the MSWiA in Warsaw" in a lesser frequency.

Most popular intervention types in "Central Clinical Hospital of the MSWiA in Warsaw" are "Drug" (5 trials), "Procedure" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Placebos" (2 trials), "Accu-Chek® Solo micropump system" (1 trials), "AtriClip® PRO LAA Exclusion System" (1 trials) and "AtriCure Bipolar System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Clinical Hospital of the MSWiA in Warsaw" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Central Clinical Hospital of the MSWiA in Warsaw". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Central Clinical Hospital of the MSWiA in Warsaw, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Clinical Hospital of the MSWiA in Warsaw, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".